⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT June 1, 2026

Imigran 6 mg/0,5 ml - Spritzampullen 6 mg/0,5 ml (Injektionslösung)

📷 Wikipedia: Sumatriptan · Source
Imigran 6 mg/0,5 ml - Spritzampullen 6 mg/0,5 ml (Injektionslösung)
📷 Wikipedia: Sumatriptan · Source
Imigran 6 mg/0.5 ml injection solution ampoules are subject to a parallel export ban.
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 102 days ago.
📈 Timeline
28 days in total
June 2, 2026 June 30, 2026

What is this? Imigran is a medicine called sumatriptan. It comes in small glass tubes for injection. It is used to treat migraine headaches.

What's happening? Some packs of Imigran are not available right now. The company expects more supplies soon.

Does this affect me? If you use Imigran, you may have trouble finding it in pharmacies in Austria.

What should I do? Ask your pharmacist or doctor for advice before changing your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
SUMATRIPTAN SUCCINAT
Agency-published detail

🚫 Parallel export ban active · ATC: N02CC01 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Glaxosmithkline Pharma GmbH, Wienerbergstraße 7, 1100 Wien, Österreich · Affected packs: 1 Stück Schachtel, Ampulle [Nicht verfügbar, since 2026-05-29, resupply 2026-06-30] · 1 Stück Schachtel, Ampulle [Nicht verfügbar, since 2026-06-01, resupply 2026-06-30]

First published
June 1, 2026
Last refreshed by us
2 months ago
Severity (as classified)
Low
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Low AT resolved 1 month ago

Sumatriptan 1A Pharma 50 mg - Tabletten 50 mg (Tablette)

Sumatriptan 1A Pharma 50 mg tablets are currently restricted from parallel export due to manufacturing capacity shortages. The affected packs are the 6-tablet box, which has been unavailable since Jun...
High AT 3 months ago

Sumanet 85 mg/500 mg Filmtabletten 85 mg/500 mg (Filmtablette)

Parallel export is banned for this medicine. Shortages in production have caused supply issues.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Imigran 6 mg/0,5 ml - Spritzampullen 6 mg/0,5 ml (Injektionslösung). Imigran 6 mg/0.5 ml injection solution ampoules are subject to a parallel export ban.
▸ When was this alert issued?
This alert was issued on June 1, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.